CNBN yields 2.18% · PFE yields 6.13%● Live data
📍 CNBN pulled ahead of the other in Year 1
Combined, CNBN + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CNBN + PFE for your $10,000?
CNB Bank Shares, Inc. operates as the bank holding company for CNB Bank & Trust. N.A. that provides banking services to individual and corporate customers in south-central Illinois, suburban southwestern Chicago, and the St. Louis metropolitan area. The company offers checking and savings accounts, certificates of deposits, time deposits, and individual retirement accounts; loans and credits, which include mortgage, construction, home equity, customer installment, student, commercial real estate, government guaranteed, term business, working capital, small business, commercial, and agricultural loans, as well as lines of credit and letters of credits; equipment financing; loans to acquire existing business; and leasing services. It provides overdraft, night depository, safe deposit box, cash management, wire transfer, cashier's check, and notary services; gift cards, and credit and debit cards; digital wallet; mobile check deposit; online and mobile banking services; wealth management, and farm management and agricultural consulting services. The company was founded in 1854 and is headquartered in Carlinville, Illinois.
Full CNBN Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.